Stockreport

RXi Pharmaceuticals Announces Closing Of $15 Million Underwritten Public Offering

RXI PHARMACEUTICALS CORP  (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com
PDF MARLBOROUGH, Mass., Oct. 3, 2018 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing the next generation of immuno- [Read more]